Related Experiment Video
Updated: May 30, 2026

Screening Foodstuffs for Class 1 Integrons and Gene Cassettes
Published on: June 19, 2015
Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid
Kathryn E Holt1, Minh Duy Phan, Stephen Baker
1Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom. kholt@unimelb.edu.au
Abstract:
Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), remains a serious global health concern. Since their emergence in the mid-1970s multi-drug resistant (MDR) S. Typhi now dominate drug sensitive equivalents in many regions. MDR in S. Typhi is almost exclusively conferred by self-transmissible IncHI1 plasmids carrying a suite of antimicrobial resistance genes. We identified over 300 single nucleotide polymorphisms (SNPs) within conserved regions of the IncHI1 plasmid, and genotyped both plasmid and chromosomal SNPs in over 450 S. Typhi dating back to 1958. Prior to 1995, a variety of IncHI1 plasmid types were detected in distinct S. Typhi haplotypes. Highly similar plasmids were detected in co-circulating S. Typhi haplotypes, indicative of plasmid transfer. In contrast, from 1995 onwards, 98% of MDR S. Typhi were plasmid sequence type 6 (PST6) and S. Typhi haplotype H58, indicating recent global spread of a dominant MDR clone. To investigate whether PST6 conferred a selective advantage compared to other IncHI1 plasmids, we used a phenotyping array to compare the impact of IncHI1 PST6 and PST1 plasmids in a common S. Typhi host. The PST6 plasmid conferred the ability to grow in high salt medium (4.7% NaCl), which we demonstrate is due to the presence in PST6 of the Tn6062 transposon encoding BetU.
Insights
Multi-drug resistant Salmonella Typhi (S. Typhi) is a global threat. A dominant clone, S. Typhi H58 with the IncHI1 PST6 plasmid, emerged in 1995, conferring a salt-growth advantage via the BetU gene.
Area of Science:
- Microbiology
- Genetics
- Epidemiology
Background:
- Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), is a significant global health issue.
- Multi-drug resistant (MDR) S. Typhi strains, primarily carrying IncHI1 plasmids, have become prevalent since the 1970s.
- Understanding the evolution and spread of MDR S. Typhi is crucial for public health.
Purpose of the Study:
- To investigate the evolutionary history and genetic diversity of IncHI1 plasmids in S. Typhi.
- To identify factors contributing to the global spread of a dominant MDR S. Typhi clone.
- To determine if specific IncHI1 plasmid types confer a selective advantage.
Main Methods:
- Genotyping of over 300 single nucleotide polymorphisms (SNPs) in conserved regions of IncHI1 plasmids.
- Analysis of plasmid and chromosomal SNPs in over 450 S. Typhi isolates from 1958 onwards.
- Phenotypic analysis comparing the growth of S. Typhi strains with different IncHI1 plasmids (PST6 vs. PST1) in various conditions.
Main Results:
- Prior to 1995, diverse IncHI1 plasmid types circulated in distinct S. Typhi haplotypes, with evidence of plasmid transfer.
- From 1995, a dominant MDR clone emerged, characterized by S. Typhi haplotype H58 and IncHI1 plasmid sequence type 6 (PST6), accounting for 98% of MDR isolates.
- The IncHI1 PST6 plasmid, unlike PST1, conferred the ability to grow in high salt (4.7% NaCl) due to the Tn6062 transposon encoding BetU.
Conclusions:
- The emergence of the S. Typhi H58/PST6 clone since 1995 has led to the global spread of MDR typhoid fever.
- The BetU gene within the Tn6062 transposon on the PST6 plasmid likely provides a selective advantage in high-salt environments.
- This study highlights the importance of plasmid evolution in driving the epidemiology of infectious diseases.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Bacterial Gastroenteritis
Plasmids
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Mechanism of Antibiotic Resistance in MRSA

